Akoons Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.70 M
- Paid Up Capital ₹ 2.70 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
- Satisfied Charges ₹ 4.00 M
- Revenue Growth 1.08%
- Profit Growth 2.79%
- Ebitda 81.45%
- Net Worth 20.47%
- Total Assets 12.10%
About Akoons Life Sciences
Akoons Life Sciences Private Limited (ALSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 December 2013 and has a history of 11 years and two months. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.70 M and a paid-up capital of Rs 2.70 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Puri and Heena Goyal serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397PB2013PTC038162
-
Company No.
038162
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Dec 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Akoons Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Puri
|
Director | 25-Jun-2020 | Current |
|
Heena Goyal
|
Director | 25-Jun-2020 | Current |
Financial Performance of Akoons Life Sciences.
Akoons Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.08% increase. The company also saw a slight improvement in profitability, with a 2.79% increase in profit. The company's net worth Soared by an impressive increase of 20.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akoons Life Sciences?
In 2023, Akoons Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹30.00 M
₹4.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Oct 2021 | Hdfc Bank Limited | ₹3.00 Cr | Open |
| 08 Dec 2020 | Others | ₹4.00 M | Satisfied |
How Many Employees Work at Akoons Life Sciences?
Unlock and access historical data on people associated with Akoons Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akoons Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akoons Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
